~~<i id='1D7D1F2A64'><strike id='1D7D1F2A64'><tt id='1D7D1F2A64'><pre id='1D7D1F2A64'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

explore

author：focus 2025-09-30 01:14:46 - browse：4

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Readout Newsletter: Geron, Novo Nordisk, WuXi updates

knowledge

hotspot

knowledge

hotspot

AdobeInJune2023,thePregnantWorkersFairnessAct(PWFA)wentintoeffect.Thefederallawrequiresemployerstogi

WSS

FDA needs staff influx to meet gene therapy needs, Marks says

Pharma patents targeted by Biden in move to slash drug prices

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Pfizer plans to depart BIO

App could help diagnose ear infections more accurately — and at home

Future doctors should be trained to promote social change

Wikipedia

explore

knowledge

What does generative AI mean for health care? We asked experts

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Spinal cord stimulation reduces pain in amputees, study finds

In age of alternative facts, a scholarly course on calling out crap

Teach medical students about patients with intellectual disabilities

Trump demands the U.S. pay no more for drugs than other countries … again

AI models in health care face new federal disclosure requirements

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA needs staff influx to meet gene therapy needs, Marks says

hotspot

CVS Caremark has created a new ploy: the drug ‘rebate credit’

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Chemotherapy shortages won’t get better under Biden’s latest plan

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Positive childhood experiences can help future health

knowledge

hotspot

hotspot

hotspot